97-17196. National Institute on Drug Abuse; Notice of Closed Meetings  

  • [Federal Register Volume 62, Number 126 (Tuesday, July 1, 1997)]
    [Notices]
    [Page 35517]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 97-17196]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    National Institutes of Health
    
    
    National Institute on Drug Abuse; Notice of Closed Meetings
    
        Pursuant to Section 10(d) of the Federal Advisory Committee Act, as 
    amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
    National Institute on Drug Abuse (NIDA) Special Emphasis Panel 
    meetings:
    
        Purpose/Agenda: To evaluate and review grant applications and 
    contract proposals.
        Name of Committee: NIDA Special Emphasis Panel.
        Date: July 15, 1997.
        Time: 9 a.m.
        Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 
    20814.
        Contact Person: Mr. Eric Zatman, Contract Review Specialist, 
    Office of Extramural Program Review, National Institute on Drug 
    Abuse, 5600 Fishers Lane, Room 10-42, Rockville, MD 20857, Telephone 
    (301) 443-1644.
    
        Name of Committee: NIDA Special Emphasis Panel.
        Date: July 22, 1997.
        Time: 2 p.m.
        Place: Office of Extramural Program Review, National Institute 
    on Drug Abuse, NIH, 5600 Fishers Lane, Room 10-42, Rockville, MD 
    20857 (Telephone Conference).
        Contact Person: William C. Grace, Ph.D., Scientific Review 
    Administrator, Office of Extramural Program Review, National 
    Institute on Drug Abuse, 5600 Fishers Lane, Room 10-42, Rockville, 
    MD 20857, Telephone (301) 443-2755.
        The meetings will be closed in accordance with provisions set 
    forth in secs 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. The 
    applications and/or proposals and the discussions could reveal 
    confidential trade secrets or commercial property such as patentable 
    material and personal information concerning individuals associated 
    with the applications, the disclosure of which would constitute a 
    clearly unwarranted invasion of personal privacy.
    
    (Catalog of Federal Domestic Assistance Program Numbers: 93.277, 
    Drug Abuse Scientist Development, Research Scientist Development, 
    and Research Scientist Awards; 93.278, Drug Abuse National Research 
    Service Awards for Research Training; 93.279, Drug Abuse Research 
    Programs, National Institutes of Health)
    
        Dated: June 24, 1997.
    LaVerne Y. Stringfield,
    Committee Management Officer, NIH.
    [FR Doc. 97-17196 Filed 6-30-97; 8:45 am]
    BILLING CODE 4140-01-M
    
    
    

Document Information

Effective Date:
7/15/1997
Published:
07/01/1997
Department:
National Institutes of Health
Entry Type:
Notice
Document Number:
97-17196
Dates:
July 15, 1997.
Pages:
35517-35517 (1 pages)
PDF File:
97-17196.pdf